Johnson Brooke Ronald, Maksutova Elmira, Boobekova Aigul, Davletova Ainura, Kazakbaeva Chinara, Kondrateva Yelena, Landoulsi Sihem, Lazdane Gunta, Monolbaev Kubanychbek, Seuc Jo Armando H
Department of Reproductive Health and Research, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
Department of Family Planning, National Center for Mother and Child Health, Bishkek, Kyrgyzstan.
Contraception. 2018 Feb;97(2):160-166. doi: 10.1016/j.contraception.2017.11.002. Epub 2017 Nov 10.
To demonstrate the feasibility and safety of training midlevel healthcare providers (midwives and family nurses) to provide medical abortion and postabortion contraception in underserved areas in Kyrgyzstan.
This was an implementation study at four referral facilities and 28 Felsher Obstetric Points in two districts to train their midwives and family nurses to deliver safe and effective abortion care with co-packaged mifepristone-misoprostol and provide contraceptives postabortion. The outcome of abortion - complete abortion, incomplete abortion or o-going pregnancy - was the primary end point measured. An international consultant trained 18 midwives and 14 family nurses (with midwifery diplomas) to provide medical abortion care. Supervising gynecologists based in the referral centers and study investigators based in Bishkek provided monthly monitoring of services and collection of patient management forms. A voluntary self-administered questionnaire at the follow-up visit documented women's acceptability of medical abortion services. All study data were cross-checked and entered into an online data management system for descriptive analysis.
Between August 2014 and September 2015, midwives provided medical abortion to 554 women with a complete abortion rate of 97.8%, of whom 62% chose to use misoprostol at home. No women were lost to follow-up. Nearly all women (99.5%) chose a contraceptive method postabortion; 61% of women receiving services completed the acceptability form, of whom more than 99% indicated a high level of satisfaction with the service and would recommend it to a friend.
This study demonstrates that trained Kyrgyz midwives and nurses can provide medical abortion safely and effectively. This locally generated evidence can be used by the Kyrgyz Ministry of Health to reduce unintended pregnancy and expand safe abortion care to women in underserved periurban and rural settings.
Success in scaling up midwife/nurse provision of medical abortion in Kyrgyzstan will require registration of mifepristone-misoprostol, regulations permanently allowing midwife/nurse provision, strengthened procurement and distribution systems to prevent stockouts of supplies, preservice training of midwives/nurses and their involvement in district level supervision, monitoring and reporting, and support from supervisors.
证明培训中级医疗服务提供者(助产士和家庭护士)在吉尔吉斯斯坦服务欠缺地区提供药物流产及流产后避孕服务的可行性和安全性。
这是一项在两个地区的四家转诊机构和28个费舍尔产科点开展的实施性研究,旨在培训其助产士和家庭护士,以便使用米非司酮 - 米索前列醇复方包装提供安全有效的流产护理,并在流产后提供避孕药具。流产结局——完全流产、不完全流产或持续妊娠——是测量的主要终点。一名国际顾问培训了18名助产士和14名(有助产士文凭的)家庭护士提供药物流产护理。转诊中心的督导妇科医生和比什凯克的研究调查员每月对服务进行监测并收集患者管理表格。随访时一份自愿自行填写的问卷记录了女性对药物流产服务的接受度。所有研究数据都经过交叉核对并录入在线数据管理系统进行描述性分析。
2014年8月至2015年9月期间,助产士为554名女性提供了药物流产服务,完全流产率为97.8%,其中62%的女性选择在家使用米索前列醇。没有女性失访。几乎所有女性(99.5%)在流产后选择了一种避孕方法;接受服务的女性中有61%填写了接受度表格,其中超过99%的女性表示对服务高度满意,并会向朋友推荐。
本研究表明,经过培训的吉尔吉斯斯坦助产士和护士能够安全有效地提供药物流产服务。吉尔吉斯斯坦卫生部可利用这一本地生成的证据来减少意外妊娠,并将安全流产护理扩展到服务欠缺的城郊和农村地区的女性。
要在吉尔吉斯斯坦成功扩大助产士/护士提供药物流产服务的规模,将需要米非司酮 - 米索前列醇的注册、永久性允许助产士/护士提供服务的规定、加强采购和分发系统以防止用品缺货、助产士/护士的岗前培训及其参与地区层面的监督、监测和报告,以及督导人员的支持。